1. Home
  2. CLNE vs EOLS Comparison

CLNE vs EOLS Comparison

Compare CLNE & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNE
  • EOLS
  • Stock Information
  • Founded
  • CLNE 2001
  • EOLS 2012
  • Country
  • CLNE United States
  • EOLS United States
  • Employees
  • CLNE N/A
  • EOLS N/A
  • Industry
  • CLNE Natural Gas Distribution
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLNE Utilities
  • EOLS Health Care
  • Exchange
  • CLNE Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • CLNE 526.3M
  • EOLS 493.5M
  • IPO Year
  • CLNE 2007
  • EOLS 2018
  • Fundamental
  • Price
  • CLNE $2.59
  • EOLS $6.66
  • Analyst Decision
  • CLNE Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • CLNE 5
  • EOLS 5
  • Target Price
  • CLNE $3.59
  • EOLS $21.25
  • AVG Volume (30 Days)
  • CLNE 1.3M
  • EOLS 897.1K
  • Earning Date
  • CLNE 11-05-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • CLNE N/A
  • EOLS N/A
  • EPS Growth
  • CLNE N/A
  • EOLS N/A
  • EPS
  • CLNE N/A
  • EOLS N/A
  • Revenue
  • CLNE $420,579,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • CLNE $1.46
  • EOLS $14.01
  • Revenue Next Year
  • CLNE $2.46
  • EOLS $29.46
  • P/E Ratio
  • CLNE N/A
  • EOLS N/A
  • Revenue Growth
  • CLNE 4.08
  • EOLS 17.15
  • 52 Week Low
  • CLNE $1.30
  • EOLS $5.71
  • 52 Week High
  • CLNE $3.67
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • CLNE 53.03
  • EOLS 48.88
  • Support Level
  • CLNE N/A
  • EOLS N/A
  • Resistance Level
  • CLNE $2.61
  • EOLS $7.58
  • Average True Range (ATR)
  • CLNE 0.10
  • EOLS 0.26
  • MACD
  • CLNE -0.11
  • EOLS -0.27
  • Stochastic Oscillator
  • CLNE 95.74
  • EOLS 86.25

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: